Adendra Therapeutics
About:
Adendra Therapeutics wants to use new insights into dendritic cell biology to develop a novel type of immunotherapy.
Website: https://adendratx.com/
Top Investors: Apple Tree Partners
Description:
Adendra is an emerging biotechnology company building on new insights into dendritic cell biology to discover and develop new small molecule and biologic medicines for the treatment of a wide range of cancers and autoimmune diseases.
Total Funding Amount:
40M GBP
Headquarters Location:
London, England, United Kingdom
Founded Date:
2021-01-01
Founders:
Caetano Reis e Sousa, Raj Mehta
Number of Employees:
1-10
Last Funding Date:
2021-12-07
IPO Status:
Private
Industries:
© 2025 bioDAO.ai